SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001493152-16-006599
Filing Date
2016-01-05
Accepted
2016-01-05 14:06:16
Documents
1
Period of Report
2015-01-09

Document Format Files

Seq Description Document Type Size
1 form4a.html 4/A  
1 form4a.xml 4/A 3727
  Complete submission text file 0001493152-16-006599.txt   4970
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences Inc (Issuer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1717 ARCH STREET SUITE 3820 PHILADELPHIA PA 19103
Business Address
Knox Thomas J (Reporting) CIK: 0001520356 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36268 | Film No.: 161321478